Fry's Path Capital focuses on making patient investments in exceptional entrepreneurs and businesses, leveraging a multi-generational capital base. The firm typically invests in Series A, B, and C rounds, supporting companies with significant growth potential. Their investment approach is tailored to the needs of each client, primarily serving families and institutions with a long-term horizon.

Notable portfolio companies include Luminoah, which has raised $6 million, and Vitara Biomedical, with $75 million raised. Fry's Path Capital is led by key partners who bring a wealth of experience and a commitment to building durable portfolios. The firm offers comprehensive investment advisory services, including asset allocation strategies, to help clients achieve their financial goals over multiple generations.

Concentration shown as share of disclosed investments by stage.